Increased VLCFA-lipids and ELOVL4 underlie neurodegeneration in frontotemporal dementia

Sci Rep. 2021 Nov 1;11(1):21348. doi: 10.1038/s41598-021-00870-x.

Abstract

Rare, yet biologically critical, lipids that contain very long chain fatty acids (VLCFA-lipids) are synthesized in the brain by the enzyme ELOVL4. High levels of VLCFA-lipids are toxic to cells and excess VLCFA-lipids are actively removed by ABCD1 in an ATP-dependent manner. Virtually nothing is known about the impact of VLCFA-lipids in neurodegenerative diseases. Here, we investigated the possible role of VLCFA-lipids in frontotemporal dementia (FTD), which is a leading cause of younger-onset dementia. Using quantitative discovery lipidomics, we identified three VLCFA-lipid species that were significantly increased in FTD brain compared to controls, with strong correlations with ELOVL4. Increases in ELOVL4 expression correlated with significant decreases in the membrane-bound synaptophysin in FTD brain. Furthermore, increases in ABCD1 expression correlated with increases in VLCFA-lipids. We uncovered a new pathomechanism that is pertinent to understanding the pathogenesis of FTD.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily D, Member 1 / analysis
  • ATP Binding Cassette Transporter, Subfamily D, Member 1 / metabolism
  • Brain / metabolism
  • Brain / pathology*
  • Eye Proteins / analysis*
  • Eye Proteins / metabolism
  • Fatty Acids / analysis*
  • Fatty Acids / metabolism
  • Frontotemporal Dementia / metabolism
  • Frontotemporal Dementia / pathology*
  • Humans
  • Membrane Proteins / analysis*
  • Membrane Proteins / metabolism
  • Synaptophysin / analysis
  • Synaptophysin / metabolism

Substances

  • ABCD1 protein, human
  • ATP Binding Cassette Transporter, Subfamily D, Member 1
  • ELOVL4 protein, human
  • Eye Proteins
  • Fatty Acids
  • Membrane Proteins
  • Synaptophysin